Recursion Pharmaceuticals, Inc. (BMV:RXRX)
110.00
-2.00 (-1.79%)
At close: Aug 5, 2025
Recursion Pharmaceuticals Revenue
Recursion Pharmaceuticals had revenue of $19.22M USD in the quarter ending June 30, 2025, with 33.34% growth. This brings the company's revenue in the last twelve months to $64.60M, up 30.14% year-over-year. In the year 2024, Recursion Pharmaceuticals had annual revenue of $58.84M with 32.00% growth.
Revenue (ttm)
$64.60M
Revenue Growth
+30.14%
P/S Ratio
35.25
Revenue / Employee
$80.75K
Employees
800
Market Cap
42.94B MXN
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 58.84M | 14.26M | 32.00% |
Dec 31, 2023 | 44.58M | 4.73M | 11.88% |
Dec 31, 2022 | 39.84M | 29.67M | 291.46% |
Dec 31, 2021 | 10.18M | 6.22M | 156.89% |
Dec 31, 2020 | 3.96M | 1.64M | 70.85% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Wal-Mart de México | 991.14B |
Grupo Financiero Banorte | 134.12B |
Arca Continental | 250.59B |
Industrias Peñoles | 141.36B |
GMéxico Transportes | 62.95B |
FIBRA Prologis | 13.44B |
Fibra UNO | 30.16B |
Promotora y Operadora de Infraestructura, S. A. B. de C. V. | 18.98B |